BioCryst’s voluntary pause turns FDA-hold as investigation reveals likely culprit behind safety signals
BioCryst’s voluntary pause turns FDA-hold as investigation reveals likely culprit [...]
Big pharma resisting temptation for biotech M&A spree until prices drop further
Big pharma resisting temptation for biotech M&A spree until prices [...]
Bavarian Nordic’s COVID-19 vaccine holds up against omicron in phase 2, fueling pivotal booster push
Bavarian Nordic’s COVID-19 vaccine holds up against omicron in phase [...]
Bancel has ‘never been as busy’ amid M&A talks as Moderna preps for life after COVID
Bancel has ‘never been as busy’ amid M&A talks as [...]
Apnimed closes $62.5M series C after working tirelessly on lead sleep disorder drug
Apnimed closes $62.5M series C after working tirelessly on lead [...]
Kezar scarred as midphase autoimmune blowup raises doubts about pipeline-in-a-drug vision
Kezar scarred as midphase autoimmune blowup raises doubts about pipeline-in-a-drug [...]
Another Pfizer gene therapy is free of FDA hold, but delay continues
Another Pfizer gene therapy is free of FDA hold, but [...]
Bad news from FDA prompts Spero to lay off 75% of staff, drop UTI drug
Bad news from FDA prompts Spero to lay off 75% [...]
After a dismal last year, Sesen Bio grasps for alternatives to stay afloat
After a dismal last year, Sesen Bio grasps for alternatives [...]
As expected, FDA spikes down Axsome migraine med, but issues are ‘addressable’
As expected, FDA spikes down Axsome migraine med, but issues [...]